Marker Therapeutics (MRKR) Price to Sales (2018 - 2025)
Marker Therapeutics' Price to Sales was 7.02 in Q4 2025, up 39.0% from 5.05 a year earlier and up 121.6% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Price to Sales (2018 - 2025) Analysis & Trends
From Q2 2018 onward, Marker Therapeutics has reported Price to Sales for 24 quarters.
- In earlier years, Price to Sales was 5.05 in FY2024 (-65.8%), 14.78 in FY2023 (+129.0%), 6.46 in FY2022 (-89.8%) and 63.58 in FY2021 (-56.8%).
- The Q4 2025 figure marks the highest quarterly Price to Sales since Q2 2024.
- Compared with a year earlier, Price to Sales was higher in two of the last seven quarters, with an average decline of 29.6%.
- The best year-over-year quarter for Price to Sales over five years was Q4 2023 (growth of 129.0%); the worst was Q1 2023 (a decline of 95.1%).
- Per Business Quant data, MRKR's Price to Sales in the three quarters before Q4 2025 was 3.17 (Q3 2025), 3.21 (Q2 2025) and 2.42 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Marker Therapeutics | 17.53 Mn | -42.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.02 |
| Sep 30, 2025 | 3.17 |
| Jun 30, 2025 | 3.21 |
| Mar 31, 2025 | 2.42 |
| Dec 31, 2024 | 5.05 |
| Sep 30, 2024 | 4.65 |
| Jun 30, 2024 | 12.97 |
| Mar 31, 2024 | 11.54 |
| Dec 31, 2023 | 15.93 |
| Sep 30, 2023 | 14.23 |
| Dec 31, 2022 | 6.46 |
| Sep 30, 2022 | 11.10 |
| Jun 30, 2022 | 15.43 |
| Mar 31, 2022 | 25.09 |
| Dec 31, 2020 | 103.08 |
| Sep 30, 2020 | 105.89 |
| Jun 30, 2020 | 141.86 |
| Dec 31, 2019 | 617.35 |
| Jun 30, 2019 | 1,749.37 |
| Dec 31, 2018 | 514.38 |
API Access
Marker Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();